Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

TAKTAK
28 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in TAKEDA PHARMACEUTICAL CO LTD

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 3.1M shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), worth $57.7M as of 2026-Q1. The position was decreased (-45.2% shares). TAK represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$57.7M

Current Shares

3.1M

Total Value Change

-$5.7M

Total Shares Change

-655,934

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
3.1M
-45.2%
$57.7M0.0%$18.08
0
2025-Q4
Increased
5.7M
+100.9%
$88.6M0.1%$15.63
48
2025-Q3
Increased
2.8M
+132.1%
$41.4M0.0%$14.62
47
2025-Q2
Decreased
1.2M
-13.0%
$18.8M0.0%$15.10
0
2025-Q1
Decreased
1.4M
-66.8%
$20.8M0.0%$14.71
0
2024-Q4
Decreased
4.2M
-9.0%
$55.8M0.0%$12.87
0
2024-Q3
Increased
4.6M
+100.2%
$459,0150.0%$13.89
39
2024-Q2
Increased
2.3M
+69.6%
$30M0.0%$12.36
43
2024-Q1
Decreased
1.4M
-28.5%
$19M0.0%$13.27
0
2023-Q4
Decreased
1.9M
-22.9%
$27.2M0.0%$13.36
0
2023-Q3
Increased
2.5M
+6.0%
$38.3M0.0%$14.48
31
2023-Q2
Increased
2.3M
+120.8%
$36.7M0.0%$14.70
47
2023-Q1
Decreased
1.1M
-72.9%
$17.4M0.0%$15.31
0
2022-Q4
Increased
3.9M
+171.3%
$60.9M0.1%$14.60
48
2022-Q3
Increased
1.4M
+39.3%
$18.7M0.0%$12.14
37
2022-Q2
Increased
1M
+538.8%
$14.5M0.0%$12.97
45
2022-Q1
New
161,713
-
$2.3M0.0%$13.51
36
2021-Q3
Exited
0
-100.0%
$00.0%$15.27
0
2021-Q2
Decreased
87,700
-66.4%
$1.5M0.0%$15.76
0
2021-Q1
Increased
261,131
+13.0%
$4.8M0.0%$17.18
30
2020-Q4
Decreased
231,178
-48.6%
$4.2M0.0%$17.02
0
2020-Q3
Decreased
449,745
-15.9%
$8M0.0%$16.98
0
2020-Q2
Increased
534,578
+28.8%
$9.6M0.0%$16.95
35
2020-Q1
Increased
415,001
+845.7%
$6.3M0.0%$14.63
44
2019-Q4
New
43,883
-
$866,0000.0%$18.41
34
2019-Q2
Exited
0
-100.0%
$00.0%$16.57
0
2019-Q1
Increased
4.2M
+11.9%
$86M0.2%$19.07
40
2018-Q4
New
3.8M
-
$63.4M0.2%$15.67
49

Other major holders of TAK: GLENVIEW CAPITAL MANAGEMENT, LLC, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used